Practical guide for the follow-up and management of patients with severe asthma treated with biologics
© 2022 Revista Medica del Instituto Mexicano del Seguro Social..
The management of severe uncontrolled asthma with biologics is an area of extreme difficulty given the scarcity of information regarding their starting criteria, the variables to be evaluated to determine the efficacy and safety of their management, the cut-off points to determine the timing to change or add another biological and the process to decrease or withdraw steroids. This review incorporates the latest information and makes a proposal based on it.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:60 |
|---|---|
| Enthalten in: |
Revista medica del Instituto Mexicano del Seguro Social - 60(2022), 2 vom: 01. März, Seite 201-210 |
| Sprache: |
Spanisch |
|---|
| Weiterer Titel: |
Guía práctica de seguimiento y manejo del paciente con asma grave tratado con biológicos |
|---|
| Beteiligte Personen: |
García-Ramírez, Ulises Noel [VerfasserIn] |
|---|
| Themen: |
Asthma |
|---|
| Anmerkungen: |
Date Completed 29.06.2022 Date Revised 05.08.2023 published: Electronic Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM342805592 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM342805592 | ||
| 003 | DE-627 | ||
| 005 | 20231226014950.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||spa c | ||
| 028 | 5 | 2 | |a pubmed24n1142.xml |
| 035 | |a (DE-627)NLM342805592 | ||
| 035 | |a (NLM)35759576 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a spa | ||
| 100 | 1 | |a García-Ramírez, Ulises Noel |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Practical guide for the follow-up and management of patients with severe asthma treated with biologics |
| 246 | 3 | 3 | |a Guía práctica de seguimiento y manejo del paciente con asma grave tratado con biológicos |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 29.06.2022 | ||
| 500 | |a Date Revised 05.08.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2022 Revista Medica del Instituto Mexicano del Seguro Social. | ||
| 520 | |a The management of severe uncontrolled asthma with biologics is an area of extreme difficulty given the scarcity of information regarding their starting criteria, the variables to be evaluated to determine the efficacy and safety of their management, the cut-off points to determine the timing to change or add another biological and the process to decrease or withdraw steroids. This review incorporates the latest information and makes a proposal based on it | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Asthma | |
| 650 | 4 | |a Benralizumab | |
| 650 | 4 | |a Drug Combinations | |
| 650 | 4 | |a Mepolizumab | |
| 650 | 4 | |a Omalizumab | |
| 650 | 4 | |a Respiratory Tract Diseases | |
| 650 | 7 | |a Biological Products |2 NLM | |
| 700 | 1 | |a Navarrete-Rodríguez, Elsy Maureen |e verfasserin |4 aut | |
| 700 | 1 | |a Chávez-García, Aurora Alejandra |e verfasserin |4 aut | |
| 700 | 1 | |a Trejo-Uribe, Vania |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Revista medica del Instituto Mexicano del Seguro Social |d 2005 |g 60(2022), 2 vom: 01. März, Seite 201-210 |w (DE-627)NLM156363798 |x 0443-5117 |7 nnns |
| 773 | 1 | 8 | |g volume:60 |g year:2022 |g number:2 |g day:01 |g month:03 |g pages:201-210 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 60 |j 2022 |e 2 |b 01 |c 03 |h 201-210 | ||